Abstract
With an average life expectancy of 14 months, Glioblastoma multiforme (GBM), is the most aggressive primary brain tumor. Our growing understanding of the immune system and its role in oncogenesis has helped develop cancer vaccines as a promising treatment modality against this disease. What follows is a comprehensive discussion on the history of immunotherapy and the various vaccine based therapies being developed and utilized for the treatment of malignant gliomas.
Keywords: Immunotherapy, Glioma, Vaccines, tumor cells, Glioblastoma multiforme (GBM), immunosuppression, central nervous system, CD8+ cells, immune system, HLA molecules
Current Drug Discovery Technologies
Title:Immunotherapy with Tumor Vaccines for the Treatment of Malignant Gliomas
Volume: 9 Issue: 4
Author(s): Divya Ajay, Luis Sanchez-Perez, Bryan D. Choi, Gabriel De Leon and John H. Sampson
Affiliation:
Keywords: Immunotherapy, Glioma, Vaccines, tumor cells, Glioblastoma multiforme (GBM), immunosuppression, central nervous system, CD8+ cells, immune system, HLA molecules
Abstract: With an average life expectancy of 14 months, Glioblastoma multiforme (GBM), is the most aggressive primary brain tumor. Our growing understanding of the immune system and its role in oncogenesis has helped develop cancer vaccines as a promising treatment modality against this disease. What follows is a comprehensive discussion on the history of immunotherapy and the various vaccine based therapies being developed and utilized for the treatment of malignant gliomas.
Export Options
About this article
Cite this article as:
Ajay Divya, Sanchez-Perez Luis, D. Choi Bryan, De Leon Gabriel and H. Sampson John, Immunotherapy with Tumor Vaccines for the Treatment of Malignant Gliomas, Current Drug Discovery Technologies 2012; 9 (4) . https://dx.doi.org/10.2174/157016312803305933
DOI https://dx.doi.org/10.2174/157016312803305933 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Connecting Switch Among Aging, Diabetes and Tumor: Avenue Leading to Cancer Therapeutics
Current Cancer Therapy Reviews Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors
Current Topics in Medicinal Chemistry Immune Checkpoint Inhibitors: Basics and Challenges
Current Medicinal Chemistry Angiogenesis and Hypoxia in Glioblastoma: A Focus on Cancer Stem Cells
CNS & Neurological Disorders - Drug Targets Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Current Drug Targets Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine Drug Delivery Across the Blood-Brain Barrier
Current Drug Delivery Tumor Protein p63/microRNA Network in Epithelial Cancer Cells
Current Genomics Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
Current Neuropharmacology Roles of TRAF6 in Central Nervous System
Current Neuropharmacology Differences in Phosphorylated Histone H2AX Foci Formation and Removal of Cells Exposed to Low and High Linear Energy Transfer Radiation
Current Genomics Cytochrome P450-based Gene Therapy for Cancer Treatment: From Concept to the Clinic
Current Drug Metabolism HSV Amplicon Vectors for Cancer Therapy
Current Gene Therapy Production of Alpha Emitters for Targeted Alpha Therapy
Current Radiopharmaceuticals Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates
Anti-Cancer Agents in Medicinal Chemistry Multi-Modality Discrimination of Brain Glioma Grades Using Diffusion Tensor and Spectroscopic MRI
Recent Patents on Medical Imaging Radiochemical Evaluation and <i>In Vitro</i> Assessment of the Targeting Ability of a Novel <sup>99m</sup>Tc-HYNIC-RGD for U87MG Human Brain Cancer Cells
Current Radiopharmaceuticals High Throughput Determination of Gains and Losses of Genetic Material Using High Resolution BAC Arrays and Comparative Genomic Hybridization
Combinatorial Chemistry & High Throughput Screening Mechanism of Action of Volatile Anesthetics: Involvement of Intracellular Calcium Signaling
Current Drug Targets - CNS & Neurological Disorders Hypoxia Helps Glioma to Fight Therapy
Current Cancer Drug Targets